‌

US Patent 9908907 Substituted piperaziniums for the treatment of emesis

Patent 9908907 was granted and assigned to Helsinn on March, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Helsinn

Current Assignee

Helsinn

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9908907

Patent Inventor Names

Emanuela Lovati0

Peter Manini0

Luca Fadini0

Valentino J Stella0

Roberta Cannella0

Alessio Venturini0

Claudio Giuliano0

Claudio Pietra0

Date of Patent

March 6, 2018

Patent Application Number

15194984

Date Filed

June 28, 2016

Patent Primary Examiner

‌

Douglas M Willis

Patent abstract

Disclosed are compounds, compositions and methods for the prevention and/or treatment of diseases which are pathophysiologically mediated by the neurokinin (NK1) receptor. The compounds have the general formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9908907 Substituted piperaziniums for the treatment of emesis

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API